(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLOUD-CLONE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CLOUD-CLONE

ST13

US500000086006884

Class

1, 5

Filing

86006884

Registration

4484849

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

09/05/2023

Trademark type

Combined

Nice classes

1, 5

Filing date

07/10/2013

Registration date

02/18/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/05/2023

Last transaction

09/05/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

06/27/2013

First use in commerce

06/27/2013

Drawing code

3

Owner type

03

Owner location

Katy, TX

Examiner

PARK, JENNY K

Law office

L40

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of a fanciful swirl design, comprised of three swirling patterns, with the words "CLOUD-CLONE" there beneath.

Holders and representatives

Holders

Cloud-Clone Corp.
Cloud-Clone Corp.

Representatives

Cloud-Clone Corp.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemical reagents used for non-medical purposes; Biochemicalsmonoclonal antibodies for in vitro scientific or research use; Enzymes for use in protein hydrolysis; Kit comprising of regeneration solutionserum samples and sensor chips for scientific use; Laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Protein arrays and nucleotide arrays for scientific and medical research; Protein for industrial use; Protein in raw material form for scientific and medical research

Class 5

Animal feed additive for use as a nutritional supplement for medical purposes; Bacterial and bacteriological preparations for medical or veterinary purposes; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Nutritional supplements; Protein supplements; Vaccines

Publications

History of USPTO decisions and trademark events.

21 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/05/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/05/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/05/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/05/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

02/20/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/18/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/18/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/18/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/18/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/15/2019

E815

TEAS SECTION 8 & 15 RECEIVED

03/15/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/18/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2013

PUBO

PUBLISHED FOR OPPOSITION

12/03/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/13/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/23/2013

DOCK

ASSIGNED TO EXAMINER

10/22/2013

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/19/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/18/2013

NWAP

NEW APPLICATION ENTERED

07/13/2013

Continuous trademark protection

Get notified about every new filing that threatens CLOUD-CLONE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.